Novonesis
439.3
DKK
+1.13 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+1.13%
+6.32%
+7.75%
+4.89%
-6.13%
+12.01%
+1.48%
+23.68%
+1,087.3%
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
205.72B DKK
Turnover
218.51M DKK
Revenue
28.59B
EBIT %
13.07 %
P/E
87.92
Dividend yield-%
0.95 %
Financial calendar
3.4
2025
General meeting '25
4.4
2025
Half year dividend
13.8
2025
Interim report Q2'25
ShowingAll content types
Trading by management and close relations of management
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools